CORGARD (Pfizer Laboratories Div Pfizer Inc)
Welcome to the PulseAid listing for the CORGARD drug offered from Pfizer Laboratories Div Pfizer Inc. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Pfizer Laboratories Div Pfizer Inc |
| NON-PROPRIETARY NAME: | nadolol |
| SUBSTANCE NAME: | NADOLOL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1979-12-10 |
| END MARKETING DATE: | 0000-00-00 |
CORGARD HUMAN PRESCRIPTION DRUG Details:
| Item Description | CORGARD from Pfizer Laboratories Div Pfizer Inc |
| LABELER NAME: | Pfizer Laboratories Div Pfizer Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/1) |
| START MARKETING DATE: | 1979-12-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 60793-800_15c2b40b-81b9-404a-9d49-b30498c8d3ef |
| PRODUCT NDC: | 60793-800 |
| APPLICATION NUMBER: | NDA018063 |
Other NADOLOL Pharmaceutical Manufacturers / Labelers:
